Öz
Koronavirüs hastalığı-2019 (COVID-19) salgını, 21 Eylül 2020’de teşhis edilen 31 milyondan fazla olguya ve 965.000’den fazla ölümle sonuçlandı. Olgu sayısı arttıkça, uzamış viral salınım, yeniden enfeksiyon ve reaktivasyon gibi klinik durumlarla daha sık karşılaşılıyor. Bu makalede, COVID-19 ile yeniden enfekte olmuş ve literatürdeki diğer olgulardan farklı olarak daha ağır ikinci hastalığı olan bir olgu sunulmuştur. Bir splenektomi olgusunda Şiddetli Akut Solunum Sendromu Koronavirüs-2 ile olası yeniden enfeksiyon, hastalığa karşı gelişen immüniteyi anlamaya yardımcı olabilir ve aşılar ve yeni tedaviler için bir rehber olabilir.
Anahtar Kelimeler: COVID-19, yeniden enfeksiyon, immünite, splenektomi
Kaynakça
Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-33.
COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Last Accessed Date: 27.09.2020. Available from: https://coronavirus.jhu.edu/map.html
Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020:368.
Li N, Wang X, Lv T. Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon. J Med Virol. 2020;92:2286-7.
Selhorst P, Van Ierssel S, Michiels J, Mariën J, Bartholomeeusen K, Dirinck E, Vandamme S, Jansens H, Ariën KK. Symptomatic SARS-CoV-2 reinfection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response. Clin Infect Dis. 2020;14;ciaa1850.
Harrington D, Kele B, Pereira S, Couto-Parada X, Riddell A, Forbes S, Dobbie H, Cutino-Moguel T. Confirmed Reinfection with SARS-CoV-2 Variant VOC-202012/01. Clin Infect Dis. 2021:ciab014.
Coronavirus (COVID-19) Mortality Rate. Last Accessed date: 26 Sep 2020. Available from: https://www.worldometers.info/coronavirus/coronavirus-death-rate/
T.C. Sağlık Bakanlığı Genel Koronavirüs Tablosu. Available from: https://covid19.saglik.gov.tr/TR-66935/genel-koronavirus-tablosu.html
Yang Y, Lu Q, Liu M, Wang Y-X, Zhang A-R, Jalali N, Dean NE, Longini I, Halloran ME, Xu B, Zhang X-A, Wang L-P, Liu W, Fang L-Q. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. medRxiv 2020.02.10.20021675.
Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, Niemeyer D, Jones TC, Vollmar P, Rothe C, Hoelscher M, Bleicker T, Brünink S, Schneider J, Ehmann R, Zwirglmaier K, Drosten C, Wendtner C. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465-9.
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395:1054-62.
Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, Kaiser L. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2021;27:315-8.
Kirkcaldy RD, King BA, Brooks JT. COVID-19 and Postinfection Immunity Limited Evidence, Many Remaining Questions. JAMA. 2020;323:2245-6.
Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536-44.
Lotfi M, Rezaei N. SARS-CoV-2: a comprehensive review from pathogenicity of the virus to clinical consequences. J Med Virol. 2020;92:1864-4.
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, Wang X, Yuan J, Li T, Li J, Qian S, Hong C, Wang F, Liu Y, Wang Z, He Q, Li Z, He B, Zhang T, Fu Y, Ge S, Liu L, Zhang J, Xia N, Zhang Z. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020:19;71:2027-34.
Roy S. COVID-19 Reinfection: Myth or Truth? SN Compr Clin Med 2020;2:710-3.
An J, Liao X, Xiao T, Qian S, Yuan J, Ye H, Qi F, Shen C, Wang L, Liu Y, Cheng X, Li N, Cai Q, Wang F, Chen J, Li G, Cai Q, Liu Y, Wang Y, Zhang F, Fu Y, He Q, Tan X, Liu L, Zhang Z. Clinical characteristics of recovered COVID-19 patients with re-detectable positive RNA test. Ann Transl Med. 2020;8:1084.
Kellam P, Barclay W. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection. J Gen Virol. 2020;101:791-7.
Channappanavar R, Fett C, Zhao J, Meyerholz DK, Perlman S. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. J Virol. 2014;88:11034-44.
Xu B, Fan C, Wang A, Yu Y-H, He C, Xia W-G, Zhang J-X, Miao Q. Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China. J Infect. 2020;81:e51-e60.
Zeng G, Xie S, Li Q, Ou J. Infectivity of severe acute respiratory syndrome during its incubation period. Biomed Environ Sci. 2009;22:502-10.
